The gemfibrozil cost-benefit model
Subtitle: analysis of data from the Helsinki Heart Study, model development and extension to the California medicaid population
By: Syam Sarma
Publisher: Rand
Published: 1993
Place of publication: Santa Monica, CA
Language: eng
Number of pages: 139
Subjects: Medicaid; Economics; Hyperlipidemias; Drug therapy; Coronary Disease; Gemfibrozil; Therapeutic use; Cost-Benefit Analysis; Coronary heart disease; Treatment; Prevention; Digoxin; Statistics
Notes: Originally presented as the author's thesis (Ph. D.)--Rand Graduate School, 1991.

"Dissertation."

"RGSD-105."

"Rand Graduate School."

Includes bibliographical references (p. 127-139).